Creative Planning’s Biostage, Inc. Common Stock BSTG Stock Holding History

Creative Planning’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-152	Closed	–	–	4521
2017 Q2	$0	Buy	+152	New	+$48	﹤0.01%	5028
2016 Q3	–	Sell	-1,000	Closed	-$1K	–	4858
2016 Q2	$1K	Buy	+1,000	New	+$1.61K	﹤0.01%	4291
2015 Q4	–	Sell	-1,000	Closed	-$1K	–	4731
2015 Q3	$1K	Buy	+1,000	New	+$1.13K	﹤0.01%	4217
2015 Q2	–	Sell	-1,000	Closed	-$3K	–	3707
2015 Q1	$3K	Sell	1,000 -11	-1%	-$37	﹤0.01%	3814
2014 Q4	$3K	Buy	+1,011	New	+$5.01K	﹤0.01%	3758

Other funds holding BSTG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GWI

Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return

Creative Planning's BSTG Position: Q3 2017 in Review

Creative Planning sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2017, closing a stake of 152 shares.

Creative Planning first reported a position in BSTG in Q4 2014 and held it in 5 quarters. The position peaked at $3K in Q1 2015. 25 funds tracked by Wall St. Rank hold BSTG as of Q3 2017.

Creative Planning reported no remaining Biostage, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 152 Biostage, Inc. Common Stock shares in Q3 2017.
Creative Planning first reported a position in Biostage, Inc. Common Stock in Q4 2014 and held it in 5 quarters.
Creative Planning's Biostage, Inc. Common Stock position peaked at $3K in Q1 2015.
25 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.